The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1098
February 19, 2001
View Complete Issue         Table of Contents 2019 
PC Spes
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
PC Spes
February 19, 2001 (Issue: 1098)
PC Spes, a dietary supplement sold for "prostate health", is being used increasingly to treat prostate cancer.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: PC Spes
Article code: 1098c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.